Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AMGN · against 16 other Healthcare companies of similar size
Ranked #9 of 17 · scores higher than 50% of peers
Bars: peers in each 10-point band of the valuation score5 peers with a valuation score of 60–69, including AMGN · Click a bar to see the companies
Mainly thanks to its free cash flow yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | AMGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 17 reported | 3.5% | 3.5% | 50% | 30% | |
| EBITDA yieldHigher is better · 17 reported | 5.9% | 6.6% | 31% | 50% | |
| Free cash flow yieldHigher is better · 16 reported | 4.1% | 4.3% | 40% | 20% | |
| Book yieldHigher is better · 16 reported | 4.7% | 17.1% | 0% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 177.5B USD | 92 | 71 | |
| 2 | 126.1B USD | 83 | 62 | |
| 3 | 162.93T ARS (≈$162.9B) | 82 | 63 | |
| 4 | 317.9B CHF (≈$365.6B) | 70 | 60 | |
| 5 | 302.7B USD | 68 | 63 | |
| 6 | 285.2B USD | 66 | 63 | |
| 6 | 171.0B USD | 66 | 45 | |
| 8 | 363.0B USD | 65 | 47 | |
| 9 | 249.4B USD | 60 | 55 | |
| 10 | 189.3B USD | 57 | 45 | |
| 11 | 134.5B USD | 55 | 70 | |
| 12 | 356.9B USD | 54 | 37 | |
| 13 | 161.8B USD | 53 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score